Beyond Air company info

What does Beyond Air do?
Beyond Air (NASDAQ:XAIR) is focused on developing innovative medical devices and therapies aimed at transforming treatment options for patients with lung diseases and severe infections. The company has a diverse portfolio of projects, including advanced systems for Nitric Oxide delivery that target a range of medical conditions, from chronic lung infections to certain types of cancer. Beyond Air's objectives are centered around harnessing the therapeutic potential of Nitric Oxide to offer safer, more effective treatments, and improving patient outcomes across the globe. Aiming to push the boundaries of medical science, Beyond Air is committed to research, development, and commercialization of cutting-edge medical technologies.
Beyond Air company media
Company Snapshot

Is Beyond Air a public or private company?


How many people does Beyond Air employ?


What sector is Beyond Air in?

pie chart
Health Care

Where is the head office for Beyond Air?

location pin
Head Office
Garden City, United States

What year was Beyond Air founded?

founded flag
Year Founded
What does Beyond Air specialise in?
/Nitric Oxide Generators /Medical Devices /Respiratory Therapies /Clinical Trials /Drug Discovery /Pulmonary Treatment

What are the products and/or services of Beyond Air?

Overview of Beyond Air offerings
LungFit PH system for generating high concentration nitric oxide (NO) from ambient air for treating various respiratory infections.
LungFit GO, a portable system for NO therapy in outpatient settings.
LungFit BRO, designed for the treatment of bronchiolitis in hospitalized infants, using nitric oxide.
Pipeline development for treating chronic obstructive pulmonary disease (COPD) with nitric oxide therapies.
Research on high-dose nitric oxide therapy for the treatment of COVID-19.
Advancements in using nitric oxide for treating nontuberculous mycobacterial (NTM) lung disease.

Who is in the executive team of Beyond Air?

Beyond Air leadership team
  • Mr. Steven Adam Lisi
    Mr. Steven Adam Lisi
    CEO & Chairman of the Board
  • Mr. Amir  Avniel
    Mr. Amir Avniel
    Co-Founder, President, Chief Business Officer & Director
  • Mr. Michael A. Gaul
    Mr. Michael A. Gaul
    Chief Operating Officer
  • Mr. Douglas Quinton Larson
    Mr. Douglas Quinton Larson
    CFO, Principal Financial Officer & Principal Accounting Officer
  • Edward  Barger
    Edward Barger
    Head of Investor Relations
  • Ms. Kori-Ann  Taylor
    Ms. Kori-Ann Taylor
    Head of Marketing
  • Dr. Andrew R. Colin M.D.
    Dr. Andrew R. Colin M.D.
    Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
  • Dr. Jeff  Myers M.D., Ph.D.
    Dr. Jeff Myers M.D., Ph.D.
    Chief Medical Officer